Cleared Traditional

K173041 - 3DIEMME RealGUIDE

K173041 is the FDA 510(k) clearance for 3DIEMME RealGUIDE by 3Diemme , Ltd.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 448-day FDA review.

K173041 · 3Diemme , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
448d
Days
Class 2
Risk

K173041 is an FDA 510(k) clearance for the 3DIEMME RealGUIDE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by 3Diemme , Ltd. (Cantu, IT). The FDA issued a Cleared decision on December 20, 2018 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all 3Diemme , Ltd. devices

Submission Details

510(k) Number K173041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2017
Decision Date December 20, 2018
Days to Decision 448 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
341d slower than avg
Panel avg: 107d · This submission: 448d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Registar Corp
Lara Luzak

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K173041.
Quantib ND
K182564 · Quantib B.V. · Dec 2018
4D View
K182750 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Dec 2018
vascuCAP
K183012 · Elucid Bioimaging, Inc. · Dec 2018
MIM - MRT Dosimetry
K182624 · Mim Software, Inc. · Dec 2018
Centricity Universal Viewer
K182419 · Ge Healthcare · Dec 2018
Vitrea Software Package, VSTP-001A
K182601 · Canon Medical Systems Corporation · Dec 2018